A

Achieve Life Sciences
D

ACHV

2.54300
USD
-0.01
(-0.27%)
مغلق
حجم التداول
48,496
الربح لكل سهم
-1
العائد الربحي
-
P/E
-2
حجم السوق
129,959,934
أصول ذات صلة
A
APVO
-0.07500
(-3.64%)
1.98500 USD
C
CRVS
0.57000
(11.74%)
5.42500 USD
C
CYCN
0.04000
(1.72%)
2.37000 USD
L
LPTX
0.02080
(8.42%)
0.26790 USD
O
OCUL
-0.015
(-0.12%)
12.620 USD
O
OGEN
-0.04000
(-3.42%)
1.13000 USD
المزيد
الأخبار المقالات

العنوان: Achieve Life Sciences

القطاع: Healthcare
الصناعة: Biotechnology
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.